Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$1.03B |
| 2 |
Broadcom
AVGO
|
$1.01B |
| 3 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$892M |
| 4 |
Amazon
AMZN
|
$876M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
$765M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$459M |
| 2 |
Yum China
YUMC
|
$421M |
| 3 |
Merck
MRK
|
$362M |
| 4 |
ASML
ASML
|
$313M |
| 5 |
Microchip Technology
MCHP
|
$298M |
Sector Composition
| 1 | Technology | 24.74% |
| 2 | Financials | 12.44% |
| 3 | Industrials | 11.72% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Puma Biotechnology
PBYI
$253M
| $47.8K | ﹤0.01% |
18,742
-100,090
| -84% | -$255K |
|
3577
Cardiff Oncology
CRDF
$144M
| $47.5K | ﹤0.01% |
17,805
-375
| -2% | -$1K |
|
|
QIPT
3578
Quipt Home Medical
QIPT
$113M
| $47.2K | ﹤0.01% |
16,158
-99,094
| -86% | -$289K |
|
3579
Acumen Pharmaceuticals
ABOS
$87.2M
| $45.1K | ﹤0.01% |
18,189
-797
| -4% | -$1.98K |
|
|
RGLS
3580
DELISTED
Regulus Therapeutics
RGLS
| $44.4K | ﹤0.01% |
28,253
-808
| -3% | -$1.27K |
|
3581
CytomX Therapeutics
CTMX
$376M
| $44.2K | ﹤0.01% |
37,464
+14,370
| +62% | +$17K |
|
|
LUNA
3582
DELISTED
Luna Innovations Incorporated
LUNA
| $43.7K | ﹤0.01% |
18,575
+6,821
| +58% | +$16K |
|
3583
Harvard Bioscience
HBIO
$21.3M
| $43.4K | ﹤0.01% |
16,123
-82,924
| -84% | -$223K |
|
|
VXRT
3584
DELISTED
Vaxart
VXRT
| $43.3K | ﹤0.01% |
50,995
+2,824
| +6% | +$2.4K |
|
3585
Atomera
ATOM
$99.8M
| $43.2K | ﹤0.01% |
+16,434
| New | +$43.2K |
|
|
EVA
3586
DELISTED
Enviva Inc.
EVA
| $42.4K | ﹤0.01% |
104,809
| – | – |
|
3587
BRC Inc
BRCC
$174M
| $41.5K | ﹤0.01% |
12,135
-25,424
| -68% | -$86.9K |
|
3588
Rekor Systems
REKR
$138M
| $40.4K | ﹤0.01% |
34,257
+201
| +0.6% | +$237 |
|
3589
AXT Inc
AXTI
$143M
| $40.4K | ﹤0.01% |
16,682
+6,378
| +62% | +$15.4K |
|
3590
D-Wave Quantum
QBTS
$5.26B
| $39.9K | ﹤0.01% |
40,568
-499
| -1% | -$490 |
|
|
SBDS
3591
Solo Brands, Inc.
SBDS
$18.8M
| $39.8K | ﹤0.01% |
28,248
-45,896
| -62% | -$64.7K |
|
3592
Precigen
PGEN
$1.3B
| $39.1K | ﹤0.01% |
41,267
-268
| -0.6% | -$254 |
|
3593
Dakota Gold
DC
$499M
| $39K | ﹤0.01% |
16,511
-289
| -2% | -$682 |
|
3594
HF Foods Group
HFFG
$170M
| $38.5K | ﹤0.01% |
10,777
-96,620
| -90% | -$345K |
|
3595
FibroBiologics
FBLG
$24.1M
| $38.4K | ﹤0.01% |
12,419
+139
| +1% | +$430 |
|
3596
Compugen
CGEN
$134M
| $38.1K | ﹤0.01% |
21,051
+2,959
| +16% | +$5.36K |
|
3597
Verastem
VSTM
$663M
| $37.1K | ﹤0.01% |
12,399
+139
| +1% | +$416 |
|
3598
Aemetis
AMTX
$151M
| $36.1K | ﹤0.01% |
15,713
-686
| -4% | -$1.58K |
|
3599
374Water
SCWO
$59.5M
| $35.9K | ﹤0.01% |
26,408
+358
| +1% | +$487 |
|
3600
FiscalNote
NOTE
$58.7M
| $35.5K | ﹤0.01% |
2,311
+27
| +1% | +$415 |
|